Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132951 · ClinicalTrials.gov registry record · Phase 4
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
A Phase 4 study, sponsored by Sanofi.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2,051
- Enrollment target
NCT00132951: Clinical Trial Phase 4 study, sponsored by Sanofi.
NCT00132951 is a Phase 4 study that was terminated before completion, run by Sanofi. The registered enrollment target is 2,051 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (296% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00132951, a Phase 4 study, was terminated before completion, sponsored by Sanofi.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2,051 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if 1 course of antibiotic treatment with telithromycin is superior to azithromycin in the treatment of lower respiratory tract infections (LRTIs), acute exacerbations of chronic bronchitis (AECBs) and community-acquired pneumonia (CAP) in the community setting.
Interventions
- DRUG Azithromycin
- DRUG Telithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,051 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Why NCT00132951 stopped before completion
NCT00132951 is an interventional study that assigns participants to a tested intervention. Its 2,051 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (296% higher).
The record links to 0 conditions, and to 2 interventions - of which Azithromycin is the first listed.
NCT00132951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00132951 about?
NCT00132951 is a clinical study titled "KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections". The purpose of this study is to determine if 1 course of antibiotic treatment with telithromycin is superior to azithromycin in the treatment of lower respiratory tract infections (LRTIs), acute exacerbations of chronic bronchitis (AECBs) and community-acquired pneumonia (CAP) in the community setti...
What is the current status of trial NCT00132951?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2,051 participants. The study started on 2004-10. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00132951?
The interventions under investigation include: Azithromycin (DRUG), Telithromycin (DRUG).
Who is sponsoring clinical trial NCT00132951?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00132951's enrollment target sits among peer trials
2,051 35th of 2000 higher than 1,966 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia